| Quarter | Filling ID |
|---|---|
| Q4 25 | 0002002654-26-000001 |
| Q3 25 | 0002002654-25-000006 |
| Q2 25 | 0002002654-25-000004 |
| Q1 25 | 0002002654-25-000003 |
| Q4 24 | 0002002654-25-000001 |
| Q3 24 | 0002002654-24-000005 |
| Q2 24 | 0002002654-24-000004 |
| Q1 24 | 0002002654-24-000002 |
| Q4 23 | 0002002654-24-000001 |
| Q3 23 | 0002002654-23-000008 |
| Q2 23 | 0002002654-23-000007 |
| Q1 23 | 0002002654-23-000006 |
| Q4 22 | 0002002654-23-000005 |
| Q3 22 | 0002002654-23-000004 |
| Q2 22 | 0002002654-23-000003 |
| Q1 22 | 0002002654-23-000002 |
| Q4 21 | 0002002654-23-000001 |
| Name | Title | CUSIP | Ticker | Value | Shares | Share Price | Investment | % of Portfolio |
|---|---|---|---|---|---|---|---|---|
| Seagen Inc. | COM | 81181C104 | $9,498,630,809 | 46,913,769 | SOLE | |||
| Incyte Corporation | COM | 45337C102 | $2,614,396,158 | 36,175,400 | SOLE | |||
| BeiGene, Ltd. | SPONSORED ADR | 07725L102 | $2,514,997,370 | 11,668,897 | SOLE | |||
| ACADIA Pharmaceuticals Inc. | COM | 4225108 | $789,282,307 | 41,938,486 | SOLE | |||
| Madrigal Pharmaceuticals, Inc. | COM | 558868105 | $374,319,075 | 1,545,113 | SOLE | |||
| BioMarin Pharmaceutical Inc. | COM | 09061G101 | $370,508,516 | 3,810,248 | SOLE | |||
| Immunocore Holdings plc | ADS | 45258D105 | $124,624,941 | 2,520,731 | SOLE | |||
| Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | $115,929,083 | 6,498,267 | SOLE | |||
| Kodiak Sciences Inc. | COM | 50015M109 | $107,325,038 | 17,310,490 | SOLE | |||
| BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | $106,008,222 | 12,710,818 | SOLE | |||
| argenx SE | SPONSORED ADR | 04016X101 | $104,381,640 | 280,159 | SOLE | |||
| Akero Therapeutics, Inc. | COM | 00973Y108 | $90,614,142 | 2,368,378 | SOLE | |||
| Kymera Therapeutics, Inc. | COM | 501575104 | $85,329,215 | 2,879,825 | SOLE | |||
| Replimune Group, Inc. | COM | 76029N106 | $80,852,425 | 4,578,280 | SOLE | |||
| AbCellera Biologics Inc. | COM | 00288U106 | $78,794,357 | 10,450,180 | SOLE | |||
| SpringWorks Therapeutics, Inc. | COM | 85205L107 | $70,875,141 | 2,753,502 | SOLE | |||
| Entrada Therapeutics, Inc. | COM | 29384C108 | $70,554,376 | 4,865,819 | SOLE | |||
| Biomea Fusion, Inc. | COM | 09077A106 | $65,398,508 | 2,108,949 | SOLE | |||
| Revolution Medicines, Inc. | COM | 76155X100 | $58,297,738 | 2,691,493 | SOLE | |||
| Prelude Therapeutics Inc. | COM | 74065P101 | $57,705,797 | 10,123,824 | SOLE | |||
| Mirati Therapeutics, Inc. | COM | 60468T105 | $52,415,769 | 1,409,784 | SOLE | |||
| FibroGen, Inc. | COM | 31572Q808 | $49,213,585 | 2,637,384 | SOLE | |||
| Cerus Corporation | COM | 157085101 | $47,720,647 | 16,067,558 | SOLE | |||
| IGM Biosciences, Inc. | COM | 449585108 | $43,372,453 | 3,156,656 | SOLE | |||
| Aerovate Therapeutics, Inc. | COM | 8064107 | $39,603,371 | 1,963,479 | SOLE | |||
| Immatics N.V. | SHS | N44445109 | $35,790,859 | 5,187,081 | SOLE | |||
| Roivant Sciences Ltd. | SHS | G76279101 | $35,257,433 | 4,777,430 | SOLE | |||
| Nurix Therapeutics, Inc. | COM | 67080M103 | $34,473,270 | 3,882,125 | SOLE | |||
| Chinook Therapeutics, Inc. | COM | 16961L106 | $33,687,926 | 1,455,202 | SOLE | |||
| Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | $30,123,449 | 2,799,577 | SOLE | |||
| DICE Therapeutics, Inc. | COM | 23345J104 | $29,675,269 | 1,035,786 | SOLE | |||
| Xenon Pharmaceuticals Inc. | COM | 98420N105 | $26,901,160 | 751,639 | SOLE | |||
| 2seventy bio, Inc. | COM | 901384107 | $25,474,765 | 2,497,526 | SOLE | |||
| Denali Therapeutics Inc. | COM | 24823R105 | $25,084,524 | 1,088,738 | SOLE | |||
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $24,698,106 | 14,614,264 | SOLE | |||
| Krystal Biotech, Inc. | COM | 501147102 | $24,235,443 | 302,716 | SOLE | |||
| Verve Therapeutics, Inc. | COM | 92539P101 | $20,426,363 | 1,416,530 | SOLE | |||
| Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | $18,886,057 | 470,974 | SOLE | |||
| Bicycle Therapeutics plc | SPONSORED ADS | 88786108 | $17,947,924 | 843,814 | SOLE | |||
| Stoke Therapeutics, Inc. | COM | 86150R107 | $17,621,415 | 2,115,416 | SOLE | |||
| AnaptysBio, Inc. | COM | 32724106 | $16,884,106 | 775,924 | SOLE | |||
| Avidity Biosciences, Inc. | COM | 05370A108 | $15,412,183 | 1,004,051 | SOLE | |||
| Blueprint Medicines Corporation | COM | 09627Y109 | $15,011,588 | 333,665 | SOLE | |||
| ARS Pharmaceuticals, Inc. | COM | 82835W108 | $13,061,996 | 2,006,451 | SOLE | |||
| Pacific Biosciences of California, Inc. | COM | 69404D108 | $13,059,716 | 1,127,782 | SOLE | |||
| Prime Medicine, Inc. | COM | 74168J101 | $12,650,132 | 1,028,466 | SOLE | |||
| Heron Therapeutics, Inc. | COM | 427746102 | $12,278,834 | 8,131,678 | SOLE | |||
| Invitae Corporation | COM | 46185L103 | $11,989,490 | 8,881,104 | SOLE | |||
| IDEAYA Biosciences, Inc. | COM | 45166A102 | $11,433,918 | 832,769 | SOLE | |||
| Cabaletta Bio, Inc. | COM | 12674W109 | $11,114,880 | 1,344,000 | SOLE |